Key takeaways

  • Have qualified counsel review the actual business; technical controls are not a legal determination.
  • Keep research-use framing consistent across storefront, checkout, imagery and communications.
  • Require appropriate checkout confirmations and retain them with the order.
  • Review overlooked surfaces, including reviews, popups, social bios and AI-generated copy.
  • Use accountable publishing, recorded changes and periodic review rather than a one-off disclaimer.

Treat research-use framing as a whole-site responsibility

See our store copy checker for the surfaces it reviews and the off, warn and block modes; it does not replace legal review.

A research-use-only website should tell a consistent story about what is offered, who the intended research audience is and which purchasing conditions apply. A footer disclaimer cannot correct a contradictory product description or image. Use this checklist to identify where presentation and operations disagree, then have the responsible people resolve those gaps. It is a technical review framework, not a substitute for a legal assessment.

Start with the technical launch checklist, and record who approves policies, catalog copy and destination rules. The exact requirements depend on your business and applicable rules. Do not borrow another store’s wording without checking that it describes your actual operation. Keep unresolved questions visible before accepting orders rather than treating the presence of a template policy as completion.

Sitewide controls visitors can actually find

Place a clear research-use-only disclaimer in the footer, near add-to-cart and in the cart. Make terms, refund, shipping and privacy policies accessible before purchase, with accurate business contact details. Policy text must agree with checkout totals, destination limits and fulfilment practices. Test the links on mobile and with keyboard navigation. A policy that cannot be reached during the decision is not a useful purchasing condition.

Choose an appropriate access model: an open store, an age gate with researcher statement, or accounts-only access. Have counsel determine the wording and minimum-age threshold. Decide which countries or states are blocked, then apply those rules before an order is accepted. A gate is not proof of eligibility, and accounts-only access does not permit contradictory claims. Recheck the controls when the catalog or destinations change.

Review patterns, not just a banned-word list

Risky language includes direct claims and implications created by context. A sentence may avoid a particular word while still presenting a product for human use. Review headings, captions, specifications, metadata and surrounding imagery together. The table below describes generic patterns to avoid, with neutral research-framed alternatives. It does not supply legal safe-harbour language; any alternative must remain accurate for the actual material and evidence.

Risky pattern categoryWhy it is riskyResearch-framed alternative
Treatment / medical claimsConnects the material to prevention, treatment or a health outcome.Describe documented identity, analytical specifications and the research-only supply context.
Dosing / administration languageProvides directions or implies a route of human use.State catalog specifications and refer only to verified laboratory documentation.
Human-use implicationsSuggests personal consumption or benefits despite an RUO label.Describe the intended research context without personal-outcome promises.
FDA approved / clinically provenMay imply an unsupported approval or clinical status.Report the actual test method, laboratory and results without approval language.
Before / after framingUses an outcome narrative or comparison to imply efficacy.Show the product label, lot identifier and relevant analytical evidence.
Athlete / bodybuilder targetingFrames the purchasing audience around performance or physique use.Address researchers and documented laboratory procurement needs.

Treatment / medical claims

Why it is riskyConnects the material to prevention, treatment or a health outcome.

Research-framed alternativeDescribe documented identity, analytical specifications and the research-only supply context.

Dosing / administration language

Why it is riskyProvides directions or implies a route of human use.

Research-framed alternativeState catalog specifications and refer only to verified laboratory documentation.

Human-use implications

Why it is riskySuggests personal consumption or benefits despite an RUO label.

Research-framed alternativeDescribe the intended research context without personal-outcome promises.

FDA approved / clinically proven

Why it is riskyMay imply an unsupported approval or clinical status.

Research-framed alternativeReport the actual test method, laboratory and results without approval language.

Before / after framing

Why it is riskyUses an outcome narrative or comparison to imply efficacy.

Research-framed alternativeShow the product label, lot identifier and relevant analytical evidence.

Athlete / bodybuilder targeting

Why it is riskyFrames the purchasing audience around performance or physique use.

Research-framed alternativeAddress researchers and documented laboratory procurement needs.

Research language must still be factual

Replacing a health promise with “for research” does not make the original implication disappear. Remove the unsupported claim rather than attaching a disclaimer to it. Do not invent laboratory findings or describe testing that was not performed. For product evidence, use the COA and lot-verification guide to keep the original report, measured results and specifications distinct. Research framing is not permission to overstate analytical quality.

Imagery and audience cues matter

Avoid syringes in use, human bodies, before-and-after comparisons and lifestyle imagery that implies consumption. Review banners, review photos, thumbnails and embedded text, not just the main product image. Prefer accurate product, label and laboratory-documentation visuals that can be inspected. A generic laboratory backdrop does not validate a product either. Alt text should describe the image honestly instead of introducing claims absent from the visible content.

Checkout confirmations need an order record

Require the appropriate research-use attestation and minimum-age confirmation at checkout, based on qualified review. The customer should understand what they are confirming before payment. Retain the confirmations with the order rather than merely recording that a gate once appeared. For your implementation, specify a timestamp and the wording or policy version so the record can be interpreted later. Do not claim that a checkbox proves the purchaser’s status.

Test acceptance, missing confirmation and blocked-destination paths. Inspect the actual order record after an authorised test transaction. Check that an alternate checkout path or account journey cannot unintentionally skip the configured condition. Retention of personal data should follow the business’s reviewed privacy approach. The payment review guide explains how consistent presentation and records support review without guaranteeing underwriting.

Find every place copy lives

Frequently forgotten surfaces include transactional emails, promotional emails, popups, promo bars, customer reviews, collection descriptions, product specifications, ad landing pages and social bios. Some are edited in different services or by different staff. Maintain an inventory with an owner and review status for each surface. Storefront checking cannot automatically cover an external social profile or a third-party email editor unless that integration actually exists.

AI-generated copy belongs in the same review process. Ask who initiated the change, which permissions were used and whether it remains a draft until reviewed. Do not publish a plausible-sounding analytical statement without evidence. A copy checker can identify patterns and reduce repeated mistakes, but it cannot determine the legality of the whole operation or detect every contextual implication. Record human review where the business requires it.

The thirty-item page-by-page checklist

Assign each item to a named reviewer and keep evidence of the check. These thirty items cover eight surfaces; they are not thirty universal legal requirements. Apply the requirements determined for your business, then test the behaviour rather than checking only the wording. A useful review identifies what is configured, what is unsupported and what needs counsel or provider input.

Home

  • 1. Make the research-use-only positioning clear without human-outcome promises.
  • 2. Review headline, banner and imagery as a combined message.
  • 3. Publish accurate business contact details and reachable policy links.
  • 4. Test the selected access gate or accounts-only journey.

Collection

  • 5. Review collection descriptions and SEO text for research framing.
  • 6. Check card labels and evidence pills against actual lot records.
  • 7. Remove audience cues implying personal performance or consumption.

Product

  • 8. Put the RUO disclaimer near the purchasing decision.
  • 9. Review descriptions, specifications, captions and metadata together.
  • 10. Match lot identifiers and COAs to the inventory offered.
  • 11. Verify analytical claims against the original laboratory report.
  • 12. Review customer text and photos before displaying them.

Cart

  • 13. Display the RUO disclaimer clearly in the cart.
  • 14. Check cart offers and promotional messages for risky implications.
  • 15. Ensure policy access and totals remain understandable on mobile.

Checkout

  • 16. Require the reviewed research-use attestation.
  • 17. Require the configured minimum-age confirmation.
  • 18. Retain confirmations with order timestamp and wording context as specified.
  • 19. Test blocked countries and states before order acceptance.
  • 20. Check final costs, policy links and all alternate checkout paths.

Account

  • 21. Test access rules without assuming an account proves eligibility.
  • 22. Protect order details and inspect retained confirmation records.
  • 23. Keep support and privacy information reachable.

Emails

  • 24. Review confirmation, invoice and dispatch messages for consistency.
  • 25. Review marketing text, imagery and subject lines before sending.
  • 26. Check support templates against actual refund and shipping policies.

Blog

  • 27. Keep articles within documented research and operational topics.
  • 28. Review headings, images and links for human-use implications.
  • 29. Verify sources and remove unsupported medical or approval claims.
  • 30. Apply the same review and publication process to AI-assisted drafts.

Make review part of normal operations

Keep an audit trail of copy changes, with a review step before publication and a periodic rescan. Include new lots, policy changes, revised emails and new promotional surfaces. Assign responsibility for responding to flags instead of allowing warnings to accumulate indefinitely. If a checker is switched off or a warning is accepted, record the reason and relevant approval. The process should remain understandable when staff or service providers change.

Schedule reviews according to the business’s risk and change cadence rather than inventing a universal interval. Keep a dated surface inventory and revisit external profiles separately. If counsel changes a rule, update the templates and test the affected journeys together. Compliance review is ongoing operational work, not a launch badge or a promise that no future issue can arise.

How Peptide Website supports the workflow

Peptide Website has a copy checker with off, warn and block modes across products, pages, sections, header and footer, cart, popups, collections, emails and AI-agent edits. It flags medical and treatment claims, dosing or injection language, human-use implications, unsupported approval language and before-and-after framing. The platform stores research-use attestation and minimum age on orders, supports access modes and configurable blocked destinations. Timestamp and wording-version requirements should be confirmed in the build scope, not assumed from that feature list.

The compliance demonstration shows the principle of checking copy before it is published. Bring the policies and review requirements established for your business to a build call so they can be translated into settings and acceptance tests. Peptide Website supplies technical guardrails; qualified advisers and your operating team remain responsible for the decisions behind them. The platform does not provide legal advice or guarantee processor approval.

Frequently asked questions

Does an RUO disclaimer make a website compliant?

No. The actual products, presentation, audience, operations and applicable rules matter. A disclaimer cannot correct contradictory claims. Have qualified counsel review the business; this checklist is not legal advice.

Is an age gate enough on its own?

No. Choose appropriate access conditions with qualified review, apply destination rules and retain required checkout confirmations. A gate or account does not prove the purchaser’s eligibility.

Should emails and reviews be checked too?

Yes. Review transactional and promotional messages, customer text and images, popups, collection text, landing pages and external profiles. Identify which surfaces are covered automatically and which require separate review.

Does Peptide Website guarantee legal compliance?

No. Its copy checker, order attestations, access modes and destination controls are technical guardrails. The business needs qualified advice, accurate content and an accountable review process.